Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-50
Closed -$7K 6247
2021
Q3
$7K Hold
50
﹤0.01% 4266
2021
Q2
$6K Hold
50
﹤0.01% 4357
2021
Q1
$8K Sell
50
-89
-64% -$18.7K ﹤0.01% 4037
2020
Q4
$28K Buy
139
+105
+309% +$20.3K ﹤0.01% 2434
2020
Q3
$6K Buy
+34
New +$7.62K ﹤0.01% 3414
2020
Q2
Sell
-28
Closed -$7.46K 5012
2020
Q1
$7K Sell
28
-28
-50% -$8.57K ﹤0.01% 2945
2019
Q4
$20K Buy
+56
New +$16K ﹤0.01% 2228

Other funds holding QTTB

Cutler Group's QTTB Position: Q4 2021 in Review

Cutler Group sold out of Q32 Bio (QTTB) in Q4 2021, closing a stake of 50 shares — an estimated $7K sold.

Cutler Group first reported a position in QTTB in Q4 2019 and held it in 7 quarters. The position peaked at $28K in Q4 2020. 120 funds tracked by Wall St. Rank hold QTTB as of Q4 2021.

  • Cutler Group reported no remaining Q32 Bio position as of Q4 2021 after selling out during the quarter.
  • Cutler Group sold 50 Q32 Bio shares in Q4 2021, an estimated $7K.
  • Cutler Group first reported a position in Q32 Bio in Q4 2019 and held it in 7 quarters.
  • Cutler Group's Q32 Bio position peaked at $28K in Q4 2020.
  • 120 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.